Malignant Breast Neoplasm (DBCOND0119988)

Identifiers

Synonyms
Malignant Neoplasm of the Breast / Malignant Neoplasm of Breast / Malignant breast neoplasm / Malignant neoplasm of breast of unspecified site / Breast cancer / Malignant neoplasm of breast (disorder) / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified / Paget's disease of the breast / Paget's Disease, Mammary / Paget's disease, mammary (morphologic abnormality) / Paget's disease of the nipple / Paget's disease of nipple / Paget's disease of nipple (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Gadobutrol
A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity.
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03777852
Emotional Evaluation and Reconstructed Breast SatisfactionNo drug interventionsotherNot Availableunknown_status
NCT01372917
Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02187991
Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancertreatment2completed
NCT03435952
Pembrolizumab with Intratumoral Injection of Clostridium Novyi-NTtreatment1active_not_recruiting
NCT05364450
Facilitating Adaptive Coping with Fear of Recurrence Among Breast Cancer SurvivorsNo drug interventionshealth_services_researchNot Availablecompleted
NCT01953003
Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancertreatment3completed
NCT01641003
Isolation and Characterization of Cancer Stem Cells Using iFP TechniqueNo drug interventionsNot AvailableNot Availableunknown_status
NCT03463954
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast TumorsNo drug interventionstreatmentNot Availablerecruiting
NCT03366428
Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancertreatment1completed
NCT03379428
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancertreatment1 / 2active_not_recruiting
NCT01639911
Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumorstreatment1completed
NCT05159778
Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)treatment2completed
NCT03429907
An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT02101385
Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast CancerNo drug interventionstreatment2completed
NCT02378337
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image QualityNo drug interventionsNot AvailableNot Availablecompleted
NCT01395706
ICG Fluorescence Technique for the Detection of Sentinel Lymph NodesNo drug interventionsdiagnostic2unknown_status
NCT01935739
Discordant HER2/Neu Status of Breast Cancer.No drug interventionsNot AvailableNot Availablecompleted
NCT03162627
Selumetinib and Olaparib in Solid Tumorstreatment1active_not_recruiting
NCT02611544
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer SurvivorsNo drug interventionshealth_services_researchNot Availablecompleted
NCT02915172
Lenvatinib and Capecitabine in Patients With Advanced Malignanciestreatment1withdrawn
NCT03261323
Breast Reconstruction Following Breast Cancer in Very High Risk PatientsNo drug interventionssupportive_careNot Availablewithdrawn
NCT04654208
Swedish Ibrance Registries Insights (SIRI)Not AvailableNot Availablerecruiting
NCT06495164
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast CancerNot AvailableNot Availableactive_not_recruiting
NCT02204098
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine TherapyNo drug interventionstreatment1active_not_recruiting
NCT02408393
MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgerytreatment3completed
NCT05033756
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDOtreatment2active_not_recruiting
NCT03425656
Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancertreatment3completed
NCT01943032
Discordant Hormonal Status of Breast Cancer.No drug interventionsNot AvailableNot Availablecompleted
NCT02131506
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancertreatment1terminated
NCT03289819
Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBCtreatment2completed
NCT02495363
Analgesic Effects of Ultrasound Guided PEC Blocks on Analgesic Opioid Consumption of Cancer Surgery PatientsNot AvailableNot Availablecompleted
NCT04327063
MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgerytreatment3completed
NCT05133674
Therapeutic Dose Monitoring (TDM) of Tamoxifentreatment2unknown_status
NCT05486520
Low-field MRI for Breast Cancer ScreeningNo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT04669873
Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT06251544
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerNo drug interventionstreatment1not_yet_recruiting
NCT02891681
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant TreatmentNo drug interventionsdiagnosticNot Availablecompleted
NCT03159195
Ibrance Real World InsightsNo drug interventionsNot AvailableNot Availablecompleted
NCT02221700
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients with Gastrointestinal or Breast MalignanciesNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03168737
18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsNo drug interventionsdiagnostic1active_not_recruiting
NCT05793957
Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related SymptomsNo drug interventionssupportive_careNot Availablecompleted
NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyNo drug interventionstreatment2recruiting
NCT05665920
Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT06090630
MR Correlated Spectroscopic Imaging for Diagnosing Breast CancerNo drug interventionsdiagnostic0completed
NCT05408260
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast CancerNo drug interventionsscreeningNot Availablerecruiting
NCT05836246
The Development of Quantitative Ultrasound Imaging Software PlatformNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04003038
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction SurgeryNo drug interventionspreventionNot Availablerecruiting